UK markets closed

Hikma Pharmaceuticals PLC (HIK.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1,438.50-2.50 (-0.17%)
At close: 05:06PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
2,550,000
2,553,000
2,341,000
2,207,000
2,070,000
Cost of revenue
1,254,000
1,252,000
1,140,000
1,059,000
1,020,000
Gross profit
1,296,000
1,301,000
1,201,000
1,148,000
1,050,000
Operating expenses
Research development
153,000
143,000
137,000
150,000
147,000
Selling general and administrative
512,000
488,000
464,000
494,000
470,000
Total operating expenses
735,000
704,000
641,000
698,000
672,000
Operating income or loss
561,000
597,000
560,000
450,000
378,000
Interest expense
54,000
56,000
56,000
39,000
41,000
Income before tax
440,000
544,000
558,000
491,000
293,000
Income tax expense
94,000
124,000
128,000
4,000
8,000
Income from continuing operations
346,000
420,000
430,000
487,000
285,000
Net income
346,000
421,000
431,000
486,000
282,000
Net income available to common shareholders
346,000
421,000
431,000
486,000
282,000
Basic EPS
-
-
1.83
2.01
1.17
Diluted EPS
-
-
1.81
2.00
1.17
Basic average shares
-
-
236,000
242,000
241,000
Diluted average shares
-
-
238,000
243,000
242,000
EBITDA
-
745,000
705,000
629,000
455,000